RxDoctor Payments Data

Hortense Bissila

Psychiatric/Mental Health · Cordova, TNNPI 1538627781

Payments from drug & device makers

$4,808in general payments, 2019–2025

Across 188 payments — averaging $25.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Indivior Inc.$1K
  • Alkermes, Inc.$786
  • E.r. Squibb & Sons, L.L.C.$777
  • Teva Pharmaceuticals USA, Inc.$415
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$413
  • Johnson & Johnson$399
  • plus $883 from 7 others

What the payments were for

  • Food & beverage$4,808100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,808 in reported general payments places this provider in the 85th percentile of 1,167 psychiatric/mental health providers in Tennessee.

See all psychiatric/mental health providers in Tennessee

Medicare billing

Part B allowed, 2024
$134,741
Medicare patients
91
Services billed
1,805

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate85$226,322
IngrezzaValbenazine Tosylate26$211,877
Abilify MaintenaAripiprazole44$124,525
PerserisRisperidone23$67,142
VraylarCariprazine Hcl12$16,290
Divalproex Sodium591$15,603
Paliperidone ErPaliperidone52$12,583
Chlorpromazine Hcl61$9,356
Olanzapine208$8,534
Aripiprazole114$7,241
Quetiapine Fumarate465$6,281
Risperidone498$6,017
Divalproex Sodium ErDivalproex Sodium124$5,855
Trazodone Hcl496$5,278
Fluphenazine Hcl46$5,064

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$399$226,32285 claims
Neurocrine Biosciences, Inc.Ingrezza$165$211,87726 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$206$124,52544 claims
Indivior Inc.Perseris$1,136$67,14223 claims
AbbVieVraylar$265$16,29012 claims
Teva Pharmaceuticals USA, Inc.Loxapine$415$1,11234 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,167 psychiatric/mental health providers in Tennessee.

Other psychiatric/mental health in Cordova

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →